Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch

Updated on: August 27,2024

Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch

Updated on:August 27,2024

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu

Updated on: December 21,2023

New factor in the development of hereditary kidney cancer discovered

by Gabriele Meseg-Rutzen,University of CologneHira-andFh1-deficient cells promote tumor initiation, growth, and invasion in vivo.(A) Scheme of xenograft injections in the flank of nu

Updated on:December 21,2023

Closing the loop to target brain glioblastomas

by Joshua Stewart,Georgia Institute of TechnologyCredit:Science Advances(2022). DOI: 10.1126/sciadv.add2288"Closing the loop" has become one of the jargony cliches of the b

Updated on: December 19,2023

Closing the loop to target brain glioblastomas

by Joshua Stewart,Georgia Institute of TechnologyCredit:Science Advances(2022). DOI: 10.1126/sciadv.add2288"Closing the loop" has become one of the jargony cliches of the b

Updated on:December 19,2023

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on: October 27,2023

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on:October 27,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on: December 21,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on:December 21,2023

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an

Updated on: December 20,2023

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an

Updated on:December 20,2023

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,

Updated on: October 23,2023

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,

Updated on:October 23,2023

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on: December 18,2023

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on:December 18,2023

Healthy diets linked to better outcomes in colorectal cancer

byAmerican Cancer SocietyCredit: CC0 Public DomainColorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved t

Updated on: December 18,2023

Healthy diets linked to better outcomes in colorectal cancer

byAmerican Cancer SocietyCredit: CC0 Public DomainColorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved t

Updated on:December 18,2023

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on: October 12,2023

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on:October 12,2023

Study shows giving entire course of radiation treatment in less than a second is feasible

byPerelman School of Medicine at the University of PennsylvaniaCancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for

Updated on: December 20,2023

Study shows giving entire course of radiation treatment in less than a second is feasible

byPerelman School of Medicine at the University of PennsylvaniaCancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for

Updated on:December 20,2023

Camrelizumab Plus Nab-Paclitaxel Showcases Antitumor Activity in Platinum-Resistant Urothelial

September 30, 2022Ryan ScottThe combination of camrelizumab and nab-paclitaxel produced encouraging responses in patients with platinum-resistant, unresectable locally advanced or metastatic urothelia

Updated on: October 17,2023

Camrelizumab Plus Nab-Paclitaxel Showcases Antitumor Activity in Platinum-Resistant Urothelial

September 30, 2022Ryan ScottThe combination of camrelizumab and nab-paclitaxel produced encouraging responses in patients with platinum-resistant, unresectable locally advanced or metastatic urothelia

Updated on:October 17,2023